Meridian Bioscience Obtains FDA Clearance For Legionella Test - Quick Facts

Trade VIVO now with

2/27/2012 1:07 PM ET

Meridian Bioscience Inc. (VIVO: Quote) announced that it has received clearance from the U.S. Food and Drug Administration for TRU Legionella, a new rapid assay for detection of legionellosis.

TRU Legionella is a rapid lateral flow device that provides optimized detection of Legionella pneumophila serogroup that is most commonly associated with Legionnaire's disease. Suspected infection is characterized by non-specific upper respiratory symptoms.

Click here to receive FREE breaking news email alerts for Meridian Bioscience Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 63 Articles

Editors Pick

Stocks Close Sharply Higher Following Upbeat Jobs Data - U.S. Commentary

After trending lower over the past few sessions, stocks showed a strong move back to the upside during trading on Friday. The markets benefited from a largely positive reaction to a better than expected monthly jobs report. The major averages closed firmly in positive territory, with the Dow and the S&P 500 back above key psychological levels.

Lawmakers Receive Mixed Messages From Upbeat Jobs Report

Although not particularly surprising, Republicans and Democrats in Washington have received mixed messages from the Labor Department's better than expected monthly jobs report on Friday. Lawmakers from both parties described the numbers as encouraging but suggested that the data provided support for their policies rather than those of their colleagues across the aisle.

U.S. Consumer Sentiment Improves Much More Than Expected In December

Consumer sentiment in the U.S. has improved by much more than anticipated in the month of December, according to a report released by Thomson Reuters and the University of Michigan on Friday. The report said the preliminary reading on the consumer sentiment index for December jumped to 82.5 from the final November reading of 75.1. Economists had been expecting the index to edge up to 75.5.